Exploiting novel valve interstitial cell lines to study calcific aortic valve disease

Tsang,Hiu‑Gwen; Cui,Lin; Farquharson,Colin; Corcoran,Brendan  M.; Summers,Kim  M.; Macrae,Vicky  E.

doi:10.3892/mmr.2017.8163

Exploiting novel valve interstitial cell lines to study calcific aortic valve disease

Authors:
- Hiu‑Gwen Tsang
- Lin Cui
- Colin Farquharson
- Brendan M. Corcoran
- Kim M. Summers
- Vicky E. Macrae
View Affiliations

Affiliations: The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian EH25 9RG, UK
Published online on: November 27, 2017 https://doi.org/10.3892/mmr.2017.8163
Pages: 2100-2106
Copyright: © Tsang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Calcific aortic valve disease (CAVD) involves progressive valve leaflet thickening and severe calcification, impairing leaflet motion. The in vitro calcification of primary rat, human, porcine and bovine aortic valve interstitial cells (VICs) is commonly employed to investigate CAVD mechanisms. However, to date, no published studies have utilised cell lines to investigate this process. The present study has therefore generated and evaluated the calcification potential of immortalized cell lines derived from sheep and rat VICs. Immortalised sheep (SAVIC) and rat (RAVIC) cell lines were produced by transduction with a recombinant lentivirus encoding the Simian virus (SV40) large and small T antigens (sheep), or large T antigen only (rat), which expressed markers of VICs (vimentin and α‑smooth muscle actin). Calcification was induced in the presence of calcium (Ca; 2.7 mM) in SAVICs (1.9 fold; P<0.001) and RAVICs (4.6 fold; P<0.01). Furthermore, a synergistic effect of calcium and phosphate was observed (2.7 mM Ca/2.0 mM Pi) on VIC calcification in the two cell lines (P<0.001). Analysis of SAVICs revealed significant increases in the mRNA expression of two key genes associated with vascular calcification in cells cultured under calcifying conditions, runt related transcription factor‑2 (RUNX2;1.3 fold; P<0.05 in 4.5 mM Ca) and sodium‑dependent phosphate transporter‑1 (PiT1; 1.2 fold; P<0.05 in 5.4 mM Ca). A concomitant decrease in the expression of the calcification inhibitor matrix Gla protein (MGP) was noted at 3.6 mM Ca (1.3 fold; P<0.01). Assessment of RAVICs revealed alterations in Runx2, Pit1 and Mgp mRNA expression levels (P<0.01). Furthermore, a significant reduction in calcification was observed in SAVICs following treatment with established calcification inhibitors, pyrophosphate (1.8 fold; P<0.01) and etidronate (3.2 fold; P<0.01). Overall, the present study demonstrated that the use of immortalised sheep and rat VIC cell lines is a convenient and cost effective system to investigate CAVD in vitro, and will make a useful contribution to increasing current understanding of the pathophysiological process.

View Figures

View References

1	Freeman RV and Otto CM: Spectrum of calcific aortic valve disease: Pathogenesis, disease progression and treatment strategies. Circulation. 111:3316–3326. 2005. View Article : Google Scholar : PubMed/NCBI
2	Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW and Otto CM: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 29:630–634. 1997. View Article : Google Scholar : PubMed/NCBI
3	Coffey S, Cox B and Williams MJ: The prevalence, incidence, progression and risks of aortic valve sclerosis: A systematic review and meta-analysis. J Am Coll Cardiol. 63:2852–2861. 2014. View Article : Google Scholar : PubMed/NCBI
4	Lindman BR, Clavel MA, Mathieu P, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW and Otto CM: Calcific aortic stenosis. Nat Rev Dis Primers. 2:160062016. View Article : Google Scholar : PubMed/NCBI
5	Balaoing LR, Post AD, Liu H, Minn KT and Grande-Allen KJ: Age-related changes in aortic valve hemostatic protein regulation. Arterioscler Thromb Vasc Biol. 34:72–80. 2014. View Article : Google Scholar : PubMed/NCBI
6	Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, Hofmann-Bowman MA, Mortlock DP, Rogers MB, Sadeghi MM and Aikawa E: Calcific aortic valve disease: A consensus summary from the alliance of investigators on calcific aortic valve disease. Arterioscler Thromb Vasc Biol. 34:2387–2393. 2014. View Article : Google Scholar : PubMed/NCBI
7	Pawade TA, Newby DE and Dweck MR: Calcification in aortic stenosis: The skeleton key. J Am Coll Cardiol. 66:561–577. 2015. View Article : Google Scholar : PubMed/NCBI
8	New SE and Aikawa E: Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res. 108:1381–1391. 2011. View Article : Google Scholar : PubMed/NCBI
9	Dweck MR, Pawade TA and Newby DE: Aortic stenosis begets aortic stenosis: Between a rock and a hard place? Heart. 101:919–920. 2015. View Article : Google Scholar : PubMed/NCBI
10	Leopold JA: Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv. 5:605–614. 2012. View Article : Google Scholar : PubMed/NCBI
11	Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG and Kaplan FS: Bone formation and inflammation in cardiac valves. Circulation. 103:1522–1528. 2001. View Article : Google Scholar : PubMed/NCBI
12	Poggio P, Sainger R, Branchetti E, Grau JB, Lai EK, Gorman RC, Sacks MS, Parolari A, Bavaria JE and Ferrari G: Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis. Cardiovasc Res. 98:402–410. 2013. View Article : Google Scholar : PubMed/NCBI
13	Monzack EL and Masters KS: Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J Heart Valve Dis. 20:449–463. 2011.PubMed/NCBI
14	Osman L, Yacoub MH, Latif N, Amrani M and Chester AH: Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation. 114:I547–I552. 2006. View Article : Google Scholar : PubMed/NCBI
15	Yip CY, Chen JH, Zhao R and Simmons CA: Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 29:936–942. 2009. View Article : Google Scholar : PubMed/NCBI
16	Cloyd KL, El-Hamamsy I, Boonrungsiman S, Grau JB, Lai EK, Gorman RC, Sacks MS, Parolari A, Bavaria JE and Ferrari G: Characterization of porcine aortic valvular interstitial cell ‘calcified’ nodules. PLoS One. 7:e481542012. View Article : Google Scholar : PubMed/NCBI
17	Gomez-Stallons MV, Wirrig-Schwendeman EE, Hassel KR, Conway SJ and Yutzey KE: Bone morphogenetic protein signaling is required for aortic valve calcification. Arterioscler Thromb Vasc Biol. 36:1398–1405. 2016. View Article : Google Scholar : PubMed/NCBI
18	Côté N, El Husseini D, Pépin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H, et al: ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol. 52:1191–1202. 2012. View Article : Google Scholar : PubMed/NCBI
19	El Husseini D, Boulanger MC, Fournier D, Mahmut A, Bossé Y, Pibarot P and Mathieu P: High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS One. 8:e533932013. View Article : Google Scholar : PubMed/NCBI
20	Seya K, Yu Z, Kanemaru K, Daitoku K, Akemoto Y, Shibuya H, Fukuda I, Okumura K, Motomura S and Furukawa K: Contribution of bone morphogenetic protein-2 to aortic valve calcification in aged rat. J Pharmacol Sci. 115:8–14. 2011. View Article : Google Scholar : PubMed/NCBI
21	Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo CL, Garner HR, Merrill WH, Hinton RB and Garg V: Inhibitory role of Notch1 in calcific aortic valve disease. PLoS One. 6:e277432011. View Article : Google Scholar : PubMed/NCBI
22	Cui L, Rashdan NA, Zhu D, Milne EM, Ajuh P, Milne G, Helfrich MH, Lim K, Prasad S, Lerman DA, et al: End stage renal disease-induced hypercalcemia may promotes aortic valve calcification via Annexin VI enrichment of valve interstitial cell-derived matrix vesicles. J Cell Physiol. 232:2985–2995. 2017. View Article : Google Scholar : PubMed/NCBI
23	Rattazzi M, Bertacco E, Iop L, D'Andrea S, Puato M, Buso G, Causin V, Gerosa G, Faggin E and Pauletto P: Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: Implications for aortic valve calcification. Atherosclerosis. 237:568–576. 2014. View Article : Google Scholar : PubMed/NCBI
24	Rattazzi M, Iop L, Faggin E, Bertacco E, Zoppellaro G, Baesso I, Puato M, Torregrossa G, Fadini GP, Agostini C, et al: Clones of interstitial cells from bovine aortic valve exhibit different calcifying potential when exposed to endotoxin and phosphate. Arterioscler Thromb Vasc Biol. 28:2165–2172. 2008. View Article : Google Scholar : PubMed/NCBI
25	Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL and Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 15:2857–2867. 2004. View Article : Google Scholar : PubMed/NCBI
26	Zhu D, Mackenzie NC, Millan JL, Farquharson C and Macrae VE: Upregulation of IGF2 expression during vascular calcification. J Mol Endocrinol. 52:77–85. 2014. View Article : Google Scholar : PubMed/NCBI
27	Zhu D, Mackenzie NC, Shanahan CM, Shroff RC, Farquharson C and MacRae VE: BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway. J Cell Mol Med. 19:165–174. 2015. View Article : Google Scholar : PubMed/NCBI
28	Mackenzie NC, Zhu D, Longley L, Patterson CS, Kommareddy S and MacRae VE: MOVAS-1 cell line: A new in vitro model of vascular calcification. Int J Mol Med. 27:663–668. 2011.PubMed/NCBI
29	Staines KA, Zhu D, Farquharson C and MacRae VE: Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling. J Bone Miner Metab. 32:240–251. 2014. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Liu AC, Joag VR and Gotlieb AI: The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 171:1407–1418. 2007. View Article : Google Scholar : PubMed/NCBI
32	Latif N, Quillon A, Sarathchandra P, McCormack A, Lozanoski A, Yacoub MH and Chester AH: Modulation of human valve interstitial cell phenotype and function using a fibroblast growth factor 2 formulation. PLoS One. 10:e01278442015. View Article : Google Scholar : PubMed/NCBI
33	Register TC and Wuthier RE: Effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone. 6:307–312. 1985. View Article : Google Scholar : PubMed/NCBI
34	Lomashvili KA, Garg P, Narisawa S, Millan JL and O'Neill WC: Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcification. Kidney Int. 73:1024–1030. 2008. View Article : Google Scholar : PubMed/NCBI
35	Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH and O'Neill WC: Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int. 75:617–625. 2009. View Article : Google Scholar : PubMed/NCBI
36	Afroze T, Yang LL, Wang C, Gros R, Kalair W, Hoque AN, Mungrue IN, Zhu Z and Husain M: Calcineurin-independent regulation of plasma membrane Ca²⁺ ATPase-4 in the vascular smooth muscle cell cycle. Am J Physiol Cell Physiol. 285:C88–C95. 2003. View Article : Google Scholar : PubMed/NCBI
37	Idelevich A, Rais Y and Monsonego-Ornan E: Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol. 31:e55–e71. 2011. View Article : Google Scholar : PubMed/NCBI
38	Kelynack KJ and Holt SG: An in vitro murine model of vascular smooth muscle cell mineralization. Methods Mol Biol. 1397:209–220. 2016. View Article : Google Scholar : PubMed/NCBI
39	Zhu D, Rashdan NA, Chapman KE, Hadoke PW and MacRae VE: A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification. Vascul Pharmacol. 86:87–93. 2016. View Article : Google Scholar : PubMed/NCBI
40	Zhu D, Hadoke PW, Wu J, Vesey AT, Lerman DA, Dweck MR, Newby DE, Smith LB and MacRae VE: Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Sci Rep. 6:248072016. View Article : Google Scholar : PubMed/NCBI
41	Johnson RC, Leopold JA and Loscalzo J: Vascular calcification: Pathobiological mechanisms and clinical implications. Circ Res. 99:1044–1059. 2006. View Article : Google Scholar : PubMed/NCBI
42	Li X, Yang HY and Giachelli CM: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 98:905–912. 2006. View Article : Google Scholar : PubMed/NCBI
43	Yao Y, Bennett BJ, Wang X, Rosenfeld ME, Giachelli C, Lusis AJ and Boström KI: Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res. 107:485–494. 2010. View Article : Google Scholar : PubMed/NCBI
44	Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR and Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386:78–81. 1997. View Article : Google Scholar : PubMed/NCBI
45	Koos R, Krueger T, Westenfeld R, Kühl HP, Brandenburg V, Mahnken AH, Stanzel S, Vermeer C, Cranenburg EC, Floege J, et al: Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost. 101:706–713. 2009.PubMed/NCBI
46	Villa-Bellosta R, Wang X, Millan JL, Dubyak GR and O'Neill WC: Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 301:H61–H68. 2011. View Article : Google Scholar : PubMed/NCBI
47	Li Q, Kingman J, Sundberg JP, Levine MA and Uitto J: Dual effects of bisphosphonates on ectopic skin and vascular soft tissue mineralization versus bone microarchitecture in a mouse model of generalized arterial calcification of infancy. J Invest Dermatol. 136:275–283. 2016. View Article : Google Scholar : PubMed/NCBI